Nour Abdallah

Nour Abdallah

Auto-generated profile, based on publicly available information

Nour Abdallah

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Kidney Cancer
Verified
Journal Article
Open access
CJChinmay T. Jani
Chinmay T. Jani
NANour Abdallah
Nour Abdallah
ATAlan Tan
Alan Tan
RMRana R. McKay
Rana R. McKay
Liquid biopsy techniques have developed rapidly in recent years and demonstrated success in cancer detection, disease characterization, and ongoing disease monitoring. These components, including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA), offer minimally invasive diagnostic tools that provide valuable insights into the genomic landscape of tumors. Its applications have expanded to include various malignancies, including renal cell carcinoma (RCC). RCC, a heterogeneous malignancy, poses unique diagnostic and therapeutic challenges. Up to 40% of patients experience recurrence or metastasis following initial surgical resection, necessitating the need for precise diagnostic and prognostic tools. The application of liquid biopsy in RCC, particularly through CTCs and ctDNA/cfDNA, holds significant promise. This review first delves into the various methodologies of CTC and cfDNA/ctDNA detection in RCC and highlights their roles in RCC management. Next, we discuss in depth about current existing evidence for the utilization of liquid biopsy in RCC diagnosis, prognosis, treatment outcomes prediction and association with the progression of the disease. Despite advancements, RCC's biological features, including low ctDNA shedding and significant intratumoral heterogeneity, present challenges in the clinical application of liquid biopsy. The review also discusses the limitations of current techniques and emphasizes the need for standardized protocols and further validation in large, diverse cohorts. Future directions include integrating liquid biopsy with advanced imaging techniques and leveraging artificial intelligence to improve RCC diagnostics and patient management. With continued refinement, liquid biopsy could become an essential tool in personalized oncology, improving outcomes for RCC patients.

20 February 2022 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
CJChinmay T. Jani
Chinmay T. Jani
CMChristian Mouchati
Christian Mouchati
NANour Abdallah
Nour Abdallah
MMMelissa Mariano
Melissa Mariano
RJRuchi Tusharkumar Jani
Ruchi Tusharkumar Jani
RMRana R. McKay
Rana R. McKay
In the United States of America (USA), prostate cancer (PC) is the most common cancer in men and the second cause of cancer mortality. Black men (BM) have a higher incidence and worse mortality when compared to white men (WM). We compared trends in PC mortality in the USA by race and state from 1999 to 2019. We extracted PC mortality data from the Centers for Disease Control (CDC) WONDER database using the International Classification of Diseases (ICD) 10 code C61. Age-Standardized Mortality Rates (ASMR) were divided into racial groups and reported by year and state. Due to the lack of available data in many states, analyses were conducted only for WM and BM using Joinpoint regression for trend comparisons. Between 1999–2019, ASMR decreased at the national level in Black (−44.6%), Asian (−44.8%), White (−31.8%), and American Indian or Alaskan native men (−19.0%). ASMR decreased in all states for both races. The greatest drop in ASMR was in Kentucky (−47.0%) for WM and Delaware (−57.8%) for BM. In 2019, ASMRs in BM (13.4/100 000) were significantly higher than WM (7.3/100 000), American Indian or Alaskan Native (3.2/100 000), and Asian men (3.2/100 000) (p < 0.001). The highest ASMRs were in Nebraska (33.5/100 000) for BM and Alaska (11/100 000) for WM. During the last 20 years, the PC mortality rate dropped in all states for all races, suggesting an advancement in management strategies. Although a higher decrease in ASMR was observed in BM, ASMR remain higher among BM. ASMRs were also found to be increasing in many states post USPSTF guideline change (2012), indicating a need for more education around optimized prostate cancer screening.

Verified
Journal Article
Open access
PDF file
CJChinmay T. Jani
Chinmay T. Jani
CMChristian F Mouchati
Christian F Mouchati
NANour Abdallah
Nour Abdallah
RJRuchi Jani
Ruchi Jani
Loukas KakoullisLoukas Kakoullis
Loukas Kakoullis
LCLin Chen
Lin Chen
Statins are among the most frequently prescribed medications. In addition to their well-established effectiveness in lowering total cholesterol, LDL, and triglycerides, statins have been described to have immunomodulatory and anti-inflammatory properties and have been associated with improved endothelial functions. Given the common use of statins, we sought to evaluate the effect of statins on some viral infections encountered by residents in tropical areas or by international travelers. A literature search was performed in PubMED/MEDLINE focusing on keywords that included statins and the viruses of interest, including SARS-CoV-2, influenza, yellow fever, dengue, Zika, tick-borne encephalitis, hemorrhagic fever viruses, hepatitis A, norovirus, hepatitis B, hepatitis C, measles, and herpesviruses; findings were synthesized for each virus into a summary. The effects of statins on viral infections vary depending on the specific virus. While some studies indicate potential benefits in chronic HBV and HCV infections, evidence regarding SARS-CoV-2 and influenza remains inconclusive due to mixed findings from observational studies and randomized controlled trials. The role of statins in other viral infections is largely unexplored, with preclinical data available for only a few viruses. Given the conflicting evidence, further prospective studies and randomized controlled trials are warranted to elucidate statins’ role in viral infections, particularly in modulating inflammation, endothelial dysfunction, and immune responses. Future research should aim to define the optimal patient populations, target viruses, statin types, and treatment durations that may confer benefits in specific viral infections.

11 February 2024 in BJU International
Verified
Journal Article
Closed access
AWAndrew M. Wood
Andrew M. Wood
NANour Abdallah
Nour Abdallah
NHNicholas Heller
Nicholas Heller
TBTarik Benidir
Tarik Benidir
FIFabian Isensee
Fabian Isensee
CWChristopher Weight
Christopher Weight

25 November 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
NRNityam Rathi
Nityam Rathi
WAWorapat Attawettayanon
Worapat Attawettayanon
AKAkira Kazama
Akira Kazama
YYYosuke Yasuda
Yosuke Yasuda
CMCarlos Munoz-Lopez
Carlos Munoz-Lopez
SCSteven C. Campbell
Steven C. Campbell

4 February 2025 in Urology
Verified
Journal Article
Closed access
NANour Abdallah
Nour Abdallah
NRNityam Rathi
Nityam Rathi
NHNicholas Heller
Nicholas Heller
AWAndrew Wood
Andrew Wood
RCRebecca Campbell
Rebecca Campbell
CWChristopher J. Weight
Christopher J. Weight